LARGE B-CELL LYMPHOMA
Clinical trials for LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR t therapy targets tough lymphoma in early trial
Disease control OngoingThis early-phase study tests a new type of CAR T cell therapy for adults with large B-cell lymphoma that has come back or not responded to treatment. The therapy uses specially modified immune cells to find and attack cancer cells. The main goals are to check safety and find the …
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Engineered immune cells take on blood cancers in new trial
Disease control OngoingThis study tests FDA-approved CAR-T cell therapy in 150 people with acute lymphoblastic leukemia or large B-cell lymphoma. The treatment uses a patient's own immune cells, modified to attack cancer. The goal is to see how many patients achieve remission and to monitor side effect…
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New CAR-T therapy shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests a new treatment called rapcabtagene autoleucel (YTB323) for adults with certain blood cancers like chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), and acute lymphoblastic leukemia (ALL). The treatment u…
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC